Validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors: Optimising the design of a subsequent randomised discontinuation trial: VALTIVE1 - CONVERIS Research Information System by Thomson Reuters:

Go to Header Go to Navigation Go to Content Go to Footer

Title: Validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors: Optimising the design of a subsequent randomised discontinuation trial: VALTIVE1

Funder
Cancer Research UK

Principal Investigator

Adams, Richard

Project Details

Net value award figure for Cardiff University: £484,126.00

Start date: 01/01/2020

End date: 31/05/2027

Our policy towards the use of cookies